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Abstract
Adults with sickle cell disease(SCD) are a growing population. Recent national estimates of outcomes in acute chest
syndrome(ACS) among adults with SCD are lacking. We describe the incidence, outcomes and predictors of mortality in ACS
in adults. We hypothesize that any need for mechanical ventilation is an independent predictor of mortality.
Methods: We performed a retrospective analysis of the Nationwide Inpatient Sample(2004–2010),the largest all payer
inpatient database in United States, to estimate the incidence and outcomes of ACS needing mechanical ventilation(MV)
and exchange transfusion(ET) in patients .21 years. The effects of MV and ET on outcomes including length of stay(LOS)
and in-hospital mortality(IHM) were examined using multivariable linear and logistic regression models respectively. The
effects of age, sex, race, type of sickle cell crisis, race, co-morbid burden, insurance status, type of admission, and hospital
characteristics were adjusted in the regression models.
Results: Of the 24,699 hospitalizations, 4.6% needed MV(2.7% for ,96 hours, 1.9% for $96 hours), 6% had ET, with a mean
length of stay(LOS) of 7.8 days and an in-hospital mortality rate(IHM) of 1.6%. There was a gradual yearly increase in ACS
hospitalizations that needed MV(2.6% in 2004 to 5.8% in 2010). Hb-SS disease was the phenotype in 84.3% of all
hospitalizations. After adjusting for a multitude of patient and hospital related factors, patients who had MV for ,
96 hours(OR = 67.53,p,0.01) or those who had MV for $96 hours(OR = 8.73,p,0.01) were associated with a significantly
higher odds for IHM when compared to their counterparts. Patients who had MV for $96 hours and those who had ET had
a significantly longer LOS in-hospitals(p,0.001).
Conclusion: In this large cohort of hospitalized adults with SCD patients with ACS, the need for mechanical ventilation
predicted higher mortality rates and increased hospital resource utilization. Identification of risk factors may enable
optimization of outcomes.
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Introduction
Survival of children with sickle cell disease well into adulthood is
commonplace in the current era, and due, at least in part, to
advances in comprehensive care of these patients [1]. In fact, a
landmark study performed nearly 20 years ago indicated that
approximately 50 percent of patients with sickle cell disease
survived beyond the fifth decade of life [2]. Acute chest syndrome
is a major complication of sickle cell disease and a significant cause
of morbidity and mortality in these patients [2,3,4]. Approximately
50 percent of patients with sickle cell disease will have an episode
of acute chest syndrome during their lifetime [5], and mortality
related to these episodes is four times higher in adults compared to
children [5,6].
A recent study of the effect of hospital type and provider
specialty on outcomes of hospitalized adolescents and young adults
(16–25 years) with sickle cell disease and acute chest syndrome
found that general hospitals carry higher intubation risks for
adolescents and young adults with sickle cell disease and acute
chest syndrome compared with children’s hospitals [7]. The
impact of the need for mechanical ventilation on outcomes in
adult patients with sickle cell disease and respiratory failure due to
acute chest syndrome is unknown.
Although, there are no randomized trials demonstrating the
optimal treatment of acute chest syndrome in adults with sickle cell
disease, transfusion therapy- especially exchange transfusion- has
remained the cornerstone of management in moderate to severe
cases of acute chest syndrome in several centers [8,9]. National
estimates of exchange transfusion usage and its impact on
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outcomes, such as in-hospital mortality and length of stay, are
largely unknown. Patient and hospital level predictors of mortality
in acute chest syndrome in sickle cell disease adult patients are also
lacking. As such, identification of risk factors can help assess
prognosis and devise preventive strategies to optimize outcomes.
The objective of our study is to estimate the incidence and
outcomes of acute chest syndrome needing mechanical ventilation
and exchange transfusion in adult patients (.21 years of age) with
sickle cell crisis. We hypothesize that the need for mechanical
ventilation predicts higher mortality in these patients.
Materials and Methods
Design and description of the database
We performed a retrospective analysis of the Nationwide
Inpatient Sample (NIS) for the years 2004 to 2010. The NIS is
the largest inpatient all-payer hospital discharge database in the
United States that is a part of the Healthcare Cost and Utilization
Project (HCUP) sponsored by the Agency for Healthcare Research
and Quality (AHRQ) [10]. The Nationwide Inpatient Sample
contains data of all nonfederal acute-care general hospitals in the
United States and has information on a multitude of patient and
hospital level variables including age, gender, race, reason for
hospitalization, secondary diagnoses, procedures performed dur-
ing hospitalization, length of stay in-hospital, hospital charges, type
of admission, insurance status, and hospital level variables
(teaching status, bed size, and geographic location).
Data user agreement
The first author (VJA) completed the data user agreement with
HCUP-AHRQ and obtained the patient/hospital de-identified
data. As per University Hospitals Case Medical Center institu-
tional review board (IRB) and in agreement with Federal
Regulations 45 CFR 46.101 (b) which states ‘‘research involving the
collection or study of existing data, documents, records, pathological specimens,
or diagnostic specimens, if these sources are publicly available or if the
information is recorded by the investigator in such a manner that subjects cannot
be identified, directly or through identifiers linked to the subjects,’’ such
studies are permitted to be classified as research that is ‘‘exempt’’
from IRB full or expedited review. IRB was not consulted for
approval since the current study was a retrospective analysis of
hospital based discharge dataset that is available publicly for
purchase from Agency for Healthcare Research and Quality
(AHRQ). The HCUP-AHRQ data user agreement precludes us
from reporting individual cell counts #10 to preserve patient
confidentiality. Consequently, these numbers were not reported in
our study.
Selection of cases and outcome variables examined
All adult hospitalizations (age .21 years) with a diagnosis of
acute chest syndrome (International Classification of Disease, 9th
edition, clinical modification [ICD-9-CM] codes of 517.3) with
sickle cell crisis (ICD-9-CM codes of 282.42, 282.62, 282.64, and
282.69) were selected. The NIS dataset has 25 diagnostic fields
and we used all these fields to select cases. For several cases, acute
chest syndrome is not the primary reason for hospitalization, but
develops during the hospitalization. Consequently, both elective
and non-elective admissions were selected for analysis. Perfor-
mance of continuous invasive mechanical ventilation (MV [ICD-
9-CM procedure codes of 96.70, 96.71, and 96.72]) and exchange
transfusion (ET [procedure code of 99.01]) was obtained for these
hospitalizations. Co-morbid burden was estimated by using the
NIS-disease severity files. The number of co-morbid conditions
was computed for each hospitalization. The types of co-morbid
conditions examined included: AIDS, alcohol abuse, deficiency
anemias, rhematoid arthritis/collage vascular diseases, chronic
blood loss anemia, congestive heart failure, chronic pulmonary
disease, coagulopathy, depression, diabetes – uncomplicated,
diabetes with chronic complications, drug abuse, hypertension,
hypothyroidism, liver disease, lymphoma, fluid and electrolyte
disorders, metastatic cancer, neurological disorders, obesity,
paralysis, peripheral vascular disorders, psychoses, pulmonary
circulation disorders, renal failure, solid tumor without metastasis,
peptic ulcer disease, valvular disease, and weight loss. Seasonal
variations in outcomes were described using simple descriptive
statistics.
Acute chest syndrome hospitalizations needing mechanical
ventilation, exchange transfusion and in-hospital mortality were
examined yearly for trends (2004 to 2010). The independent
variables of interest included a set of factors at both patient level
(age, gender, type of admission, insurance status, race/ethnicity,
type of sickle cell crisis, and presence of co-morbid conditions) and
hospital level (hospital teaching status, bed size, and hospital
location). The type of sickle cell crisis examined included Sickle-
cell thalassemia with crisis (ICD 9 CM Code 282.42), Hb-SS
disease with crisis (282.62), Sickle-cell/HB-C disease with crisis
(282.64), and other sickle-cell disease with crisis (282.69).
Analytical approach
The effects of mechanical ventilation and exchange transfusion
on outcomes including length of stay (LOS) and in-hospital
mortality were examined using multivariable linear and logistic
regression models respectively. Since length of stay was skewed, it
was log transformed and used as the dependent variable in the
regression model. Taylor Linearization Methods was used to
estimate the standard errors. In the multivariable logistic
regression model for predicting in-hospital mortality, the odds
ratios and 95% confidence intervals were computed for each level
of independent variable. In both multivariable regression models,
the effects of clustering of outcomes within-hospitals were
accounted for. The effects of age, sex, type of sickle cell crisis,
race, co-morbid burden, insurance status, type of admission, and
hospital characteristics were adjusted in the regression models. All
statistical analyses were conducted using SAS Version 9.3 (SAS
Institute, Cary, NC) and SUDAAN Version 10.0.1 (Research
Triangle Park, NC). All statistical tests were two-sided and a p-
value of ,0.05 was deemed to be statistically significant.
Results
There were a total a total of 24,699 hospitalizations for sickle
cell crisis with acute chest syndrome (range is 2,818 hospitaliza-
tions in year 2004 to 4,796 hospitalizations in year 2010) See
Figure 1. Hb-SS disease was the phenotype in 84.3% of all
hospitalizations, while 4.2% had sickle-cell thalassemia, 2.5% had
sickle-cell/Hb-C disease, and 9.8% had other forms of sickle-cell
disease (Table 1). Close to 2.7% of patients required mechanical
ventilation for less than 96 consecutive hours, 1.9% had
mechanical ventilation for 96 consecutive hours or more, and
6% had an exchange transfusion. There was a gradual yearly
increase in the number of acute chest syndrome hospitalizations
that needed mechanical ventilation. Use of exchange transfusions
varied on yearly basis with the lowest being in 2007, the year when
mechanical ventilation use was higher than exchange transfusions
- See figure 1.
The characteristics of hospitalizations are summarized in table 2.
The mean patient age was 33 years and males comprised 48.6% of
all hospitalizations. A total of 20,089 hospitalizations had
Acute Chest Syndrome Outcomes in Adults
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information on race. Of these, 92.3% were classified as blacks,
4.3% as Hispanics, 1.4% as whites, 0.3% as Asians/pacific
islanders, 0.2% as Native Americans, and 1.4% were other races.
A concomitant co-morbid condition was present in 63.7% of all
hospitalizations. Close to 95.5% of all hospitalizations occurred on
an emergent or urgent basis. About 29.6% of the hospitalizations
were covered by Medicare, 40.5% by Medicaid, 20.2% by private
insurance, and 3% by other insurance plans. About 6.7% were
uninsured. About 73.5% were treated in teaching hospitals. Large
bed size hospitals treated 72% of hospitalizations.
Disposition status following hospitalization is summarized in
table 3. Routine discharge was the outcome in 86.2% of the
hospitalizations, while, 1.7% were transferred to another acute
care hospital, 1.9% were transferred to a long term care facility,
5.3% were discharged to a home health care facility, and 3.2%
were discharged against medical advice. A total of 393 patients
died in-hospitals (mortality rate of 1.6%).
Results of the multivariable analysis examining predictors of in-
hospital mortality are summarized in table 4. Patients who had
mechanical ventilation for less than 96 consecutive hours
(OR=67.53, 95% CI= 34.12–133.63, p,0.01) or those who
had mechanical ventilation for 96 consecutive hours or more
(OR=8.73, 95% CI= 2.16–35.24, p,0.01) were associated with a
significantly higher odds for in-hospital mortality when compared
to those who did not require mechanical ventilation.
The mean hospital LOS was 7.8 days. Results of the
multivariable analysis examining predictors of length of stay are
summarized in table 5. Patients who had mechanical ventilation
for 96 consecutive hours or more (estimate = 0.9252, 95%
CI= 0.81816–1.0318, p,0.001) and those who had an exchange
transfusion had a significantly longer hospitalizations (estimate
= 0.4033 95% CI= 0.3120–0.4947, p,0.001) after adjusting for
all other patient and hospital related factors. Increase in age was
associated with shorter hospital length of stay (estimate =2
0.0066, 95% CI=20.0094–20.0038, p,0.001). Females were
associates with longer length of stay compared to males (estimate
= 0.0880, 95% CI= 0.0376–0.1384, p,0.001). Patients hospital-
ized on an elective basis had longer length of stay (estimate
Figure 1. Acute Chest Syndrome Hospitalizations and Outcomes per year. The descriptive figure shows the number of acute chest
syndrome hospitalizations per year- identified by ‘‘n’’ (2004 to 2010)- Right y axis. Outcomes such as Exchange transfusion(%), Mechanical
Ventilation(%) and Mortality(%) are shown as percentages of acute chest syndrome hospitalizations.(2004 to 2010)- Left y axis.
doi:10.1371/journal.pone.0094387.g001
Table 1. Type of sickle cell crisis and procedures performed.
Type of sickle cell crisis (ICD-9-CM Code) N (%)
Sickle-cell thalassemia with crisis (282.42) 1029 (4.2%)
Hb-SS disease with crisis (282.62) 20814 (84.3%)
Sickle-cell/HB-C disease with crisis (282.64) 629 (2.5%)
Other sickle-cell disease with crisis (282.69) 2415 (9.8%)
Procedures (ICD-9-CM procedure code)
Continuous invasive mechanical ventilation for less than 96 consecutive hours (96.71) 665 (2.7%)
Continuous invasive mechanical ventilation for 96 consecutive hours or more (96.72) 468 (1.9%)
Exchange transfusion (99.01) 1489 (6%)
(N = 24699).
doi:10.1371/journal.pone.0094387.t001
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Table 2. Characteristics of hospitalizations.
Characteristic Response N (%)
Sex Male 11999 (48.6%)
Female 12696 (51.4%)
Race White 288 (1.4%)
Black 18552 (92.3%)
Hispanic 871 (4.3%)
Asian/Pacific Islander 55 (0.3%)
Native American 44 (0.2%)
Other/Mixed races 278 (1.4%)
Insurance Medicare 7300 (29.6%)
Medicaid 9976 (40.5%)
Private 4978 (20.2%)
Uninsured 1643 (6.7%)
Other insurance 738 (3%)
Type of admission Emergency/Urgent 23556 (95.5%)
Elective 1099 (4.5%)
Number of co-morbid conditions 0 8967 (36.3%)
1 7694 (31.1%)
2 4414 (17.9%)
3 2032 (8.2%)
4 974 (3.9%)
5 414 (1.7%)
6 155 (0.6%)
7 35 (0.1%)
.=8 13 (0.05%)
Types of co-morbid conditions AIDS 89 (0.4%)
Alcohol abuse 241 (1%)
Deficiency anemias 556 (2.2%)
Rhematoid arthritis/collage vascular diseases 278 (1.1%)
Chronic blood loss anemia 144 (0.6%)
Congestive heart failure 1699 (6.9%)
Chronic pulmonary disease 3546 (14.3%)
Coagulopathy 1294 (5.2%)
Depression 1596 (6.5%)
Diabetes – uncomplicated 648 (2.6%)
Diabetes with chronic complications 69 (0.3%)
Drug abuse 1742 (7%)
Hypertension 3552 (14.4%)
Hypothyroidism 280 (1.1%)
Liver disease 577 (2.3%)
Lymphoma 54 (0.2%)
Fluid and electrolyte disorders 6221 (25.2%)
Metastatic cancer 0
Neurological disorders 1102 (4.5%)
Obesity 559 (2.3%)
Paralysis 294 (1.2%)
Peripheral vascular disorders 106 (0.4%)
Psychoses 595 (2.4%)
Pulmonary circulation disorders 2564 (10.4%)
Renal failure 1023 (4.1%)
Solid tumor without metastasis 25 (0.1%)
Acute Chest Syndrome Outcomes in Adults
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=0.2428 95% CI= 0.1364–0.3492, p,0.001) compared to those
hospitalized on an emergent or urgent basis. Those covered by
Medicaid (estimate = 0.0940, 95% CI= 0.0009–0.1871,
p = 0.048) and other insurance plans (estimate = 0.1974, 95%
CI= 0.0561–0.3386, p= 0.006) were associated with longer length
of stay compared to the uninsured. Large bed size hospitals were
associated with longer length of stay compared to small/medium
bed size hospitals (estimate = 0.0655 95% CI= 0.0033–0.1277,
p = 0.04). Seasonal variation in acute chest syndrome hospitaliza-
tions, mechanical ventilation and in-hospital mortality is shown in
table 6.
Discussion
Advances in medical technology, immunizations, infection
control, improved patient education, and multidisciplinary care
have led to an increasing number of adults living with sickle cell
disease [12,13]. Although it is known that disease severity and
mortality rate are much higher in adults with sickle cell disease and
acute chest syndrome compared to children [2,6,11], current
national estimates of hospital resource utilization and outcomes in
adults with acute chest syndrome are lacking. To our knowledge,
our study is the largest cohort of hospitalized adult patients with
sickle cell disease and acute chest syndrome whose outcomes were
assessed using a multitude of patient and hospital level character-
istics at a national level.
Consistent with prior studies [3,14], we showed that adults with
Hb-SS phenotype accounted for the highest rate of acute chest
syndrome hospitalizations. Further, in the present study, although,
Hb-SS disease with crisis accounted for the majority of hospital-
izations, neither the in-hospital mortality nor the length of stay
were influenced by the genotype of sickle cell disease. This could
suggest that, rather than the genotype, it is the severity of acute
chest syndrome and resulting respiratory failure (as evidenced by
the need of mechanical ventilation) that influences mortality.
In our study, acute respiratory failure requiring mechanical
ventilation was found in 4.6% of hospitalizations with an overall
all cause in-hospital mortality rate of 1.6% which is lower in
comparison to the 13% mechanical ventilation and 3% mortality
in the National Acute Chest Syndrome Group (NACS-671
episodes) study [5,18]. This lower mortality could be due to the
advances in medical care and management strategies over the past
decade. Interestingly, the mortality for patients with acute chest
syndrome patients requiring mechanical ventilation in the NACS
study was better than the overall mortality rate for patients with
acute chest syndrome (19% compared to approximately 30%,
respectively). It is very intriguing to note that, in our study, any
need for mechanical ventilation was an independent predictor of
mortality, with the odds of mortality being highest in the first
Table 2. Cont.
Characteristic Response N (%)
Peptic ulcer disease DS
Valvular disease 721 (2.9%)
Weight loss 292 (1.2%)
Hospital teaching status Non-teaching status 6472 (26.5%)
Teaching status 17963 (73.5%)
Hospital bed size Small 1711 (7%)
Medium 5128 (21%)
Large 17596 (72%)
Hospital region Northeast 6492 (26.3%)
Midwest 4289 (17.4%)
South 11530 (46.7%)
West 2388 (9.7%)
Age in years Mean 33.2
Standard error 0.19
DS: Discharge information is suppressed as individual cell count is ,= 10 (as per data user agreement with HCUP-AHRQ).
doi:10.1371/journal.pone.0094387.t002
Table 3. Disposition status.
Disposition status N (%)
Routine discharge 21287 (86.2%)
Transfer to another acute care facility 431 (1.7%)
Transfer to another long term care facility (eg. Skilled nursing facility) 464 (1.9%)
Home health care 1313 (5.3%)
Discharged against medical advice 793 (3.2%)
In-hospital mortality 393 (1.6%)
doi:10.1371/journal.pone.0094387.t003
Acute Chest Syndrome Outcomes in Adults
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96 hours. Our results are consistent with a single center intensive
care unit experience of higher risk of mortality in invasively
mechanically ventilated patients (12–52 years) with acute chest
syndrome [29]. Our results contrast those of a recent study in
adolescents and young adults (16–25 years) with sickle cell disease
admitted with acute chest syndrome in that although nearly 45%
of those patients required mechanical ventilation, the in-hospital
mortality was 0.6% of all hospitalizations [7].
The mean length of hospitalization in our study was 7.8 days
which is lower compared to 10.5 days in the NACS study [18]. In
our study, the predictors of increased LOS included mechanical
ventilation ($96 hours), need for exchange transfusion and
increased co morbid burden, factors that are intuitively anticipated
to cause increased LOS. It is of interest to note that in our study
for every 1 year increase in age, the LOS was lower, although
marginally low. A prior study using similar national administrative
database found that older children with sickle cell disease and
vaso-occlusive crisis had a longer LOS [25].
Prior studies have demonstrated that both simple and exchange
transfusions alleviate organ dysfunction in patients with sickle cell
crisis and acute chest syndrome [5,15,16,17]. Although, no
definitive randomized controlled trials exist to evaluate the timing
of blood transfusion (simple or exchange) in acute chest syndrome
in adults, most experts recommend no transfusions for mild, simple
transfusions for moderate and exchange transfusions for severe
acute chest syndrome. In our study, 6% of the hospitalizations
received exchange transfusion and after adjustment of known
confounding factors, exchange transfusion was not an independent
predictor of in-hospital mortality, although it did lead to a 40%
increase in length of stay. This is in sharp contrast to the exchange
transfusion rate of 3% in adolescents/young adults hospitalized for
acute chest syndrome [7]. The timing and impact of exchange
transfusion on outcomes in the adult population merits further
research.
A prior study showed that hospitals with low volume of
admissions for sickle cell disease had higher mortality rates
compared to high volume hospitals [24], a finding that is true
across other disease processes as well [26,27]. In contrast, our
study found that a multitude of patient and hospital level factors
such as increasing age, race, gender, co-morbid conditions,
insurance, teaching status, hospital bed size or region did not
influence the in-hospital mortality rate, further underscoring that
the severity of illness and need for mechanical ventilation are more
pertinent factors. No prior study has looked at seasonal variations
in outcomes for sickle cell disease patients with acute chest
syndrome. In the present study, the in-hospital mortality ranged
from a low of 1.24% (April–June) to a high of 2.20% (July–
September). The impact of viral infections (which have seasonal
variation) on sickle cell acute chest syndrome hospitalization
outcomes merits further research.
The particular strength of our study rests on the size and
breadth of our sample. NIS is the largest all-payer hospital
Table 4. Predictors of In-hospital mortality.
Characteristic Response OR (95% CI) p-value
Type of sickle cell crisis Hb-SS disease with crisis 0.71 (0.33–1.51) 0.37
All other crisis Reference
Procedure Continuous invasive mechanical ventilation for ,96 consecutive hours 67.53 (34.12–133.63) ,0.001
Continuous invasive mechanical ventilation for $96 consecutive hours 8.73 (2.16–35.24) ,0.001
Exchange transfusion 0.13 (0.02–1.16) 0.07
Age in years Each 1 year increase in age 1.02 (0.99–1.06) 0.17
Sex Female 0.67 (0.33–1.35) 0.26
Male Reference
Race Black 0.27 (0.05–1.49) 0.13
White Reference
Type of admission Elective 0.86 (0.15–4.95) 0.87
Emergency/Urgent Reference
Comorbid conditions Each 1 unit increase in co-morbid conditions 1.17 (0.97–1.41) 0.11
Insurance status Medicare 1.21 (0.24–6.06) 0.82
Medicaid 2.08 (0.41–10.46) 0.38
Private insurance 2.04 (0.43–9.77) 0.37
Other insurance 0.70 (0.03–14.94) 0.82
Uninsured Reference
Teaching status of hospital Teaching 1.46 (0.67–3.21) 0.34
Non teaching Reference
Hospital bed size Large bed 0.95 (0.48–1.91) 0.89
Small/Medium Reference
Hospital region Northeast 0.78 (0.23–2.65) 0.69
Midwest 1.09 (0.28–4.30) 0.90
South 0.58 (0.18–1.85) 0.36
West Reference
doi:10.1371/journal.pone.0094387.t004
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Table 5. Predictors of length of stay in-hospital.
Characteristic Response Estimate* (95% CI) p-value
Type of sickle cell crisis Hb-SS disease with crisis 20.0054 (20.0769–0.0660) 0.88
All other crisis Reference
Procedure Continuous invasive mechanical ventilation for ,96 consecutive hours 0.0398 (20.1290–0.2087) 0.64
Continuous invasive mechanical ventilation for $96 consecutive hours 0.9252 (0.81816–1.0318) ,0.001
Exchange transfusion 0.4033 (0.3120–0.4947) ,0.001
Age in years Each 1 year increase in age 20.0066 (20.0094–20.0038) ,0.001
Sex Female 0.0880 (0.0376–0.1384) ,0.001
Male Reference
Race Black 20.0373 (20.2424–0.1678) 0.72
Hispanic 20.1428 (20.3721–0.0866) 0.22
Asian/Pacific islanders 20.1910 (20.5377–0.1557) 0.28
Native Americans 20.0619 (20.4368–0.3129) 0.75
Other races 0.1458 (20.1217–0.4132) 0.28
White Reference
Type of admission Elective 0.2428 (0.1364–0.3492) ,0.001
Emergency/Urgent Reference
Co-morbid conditions Each 1 unit increase in co-morbid conditions 0.1062 (0.0864–0.1260) ,0.001
Insurance status Medicare 0.0870 (20.0145–0.1886) 0.09
Medicaid 0.0940 (0.0009–0.1871) 0.048
Private insurance 0.0109 (20.0947–0.1164) 0.84
Other insurance 0.1974 (0.0561–0.3386) 0.006
Uninsured Reference
Teaching status of hospital Teaching 0.0560 (20.0106–0.1226) 0.10
Non teaching Reference
Hospital bed size Large bed 0.0655 (0.0033–0.1277) 0.04
Small/Medium Reference
Hospital region Northeast 0.0348 (20.0709–0.1406) 0.52
Midwest 0.0219 (20.0945–0.1384) 0.71
South 0.0582 (20.0428–0.1591) 0.26
West Reference
Mean length of stay in-hospital is 7.8 days (standard error is 0.13)
*Positive estimate implies increased LOS compared to the reference variable. Negative estimate implies decreased LOS compared to the reference variable.
doi:10.1371/journal.pone.0094387.t005
Table 6. Sensitivity Analysis to Examine Seasonal Variations.
Variable January–March April–June July–September October–December
Sickle-cell thalassemia with crisis (282.42) 291 172 265 301
Hb-SS disease with crisis (282.62) 5336 4771 5308 5372
Sickle-cell/HB-C disease with crisis (282.64) 113 113 211 181
Other sickle-cell disease with crisis (282.69) 592 495 663 655
Continuous invasive mechanical ventilation for ,96 consecutive
hours (96.71)
162 176 192 136
Continuous invasive mechanical ventilation for $96 consecutive
hours (96.72)
123 102 115 129
Exchange transfusion (99.01) 347 333 373 436
In-hospital mortality(total number) 88 69 142 93
In-hospital mortality as % of all hospitalizations 1.39% 1.24% 2.20% 1.42%
Note: For 47 hospitalizations, information on discharge quarter was not available.
doi:10.1371/journal.pone.0094387.t006
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discharge database in United States and represents experiences
beyond a single center. The outcomes assessed in this large cohort
of patients reflect the impact of advances in medical care in the
given time frame. Identifying predictors of worse outcomes is
useful in devising preventive management strategies to optimize
outcomes. There are, however, several methodological limitations
to this study. Due to its retrospective nature, the cause and effect
relationship between the independent variables and occurrence of
a particular event cannot be firmly established. There are also
inhered limitations associated with the use of a large secondary
hospital discharge administrative datasets. Nevertheless, a recent
study demonstrated the effective use of a large multi-institute
administrative dataset in assessing the outcomes of adolescents and
young adults with acute chest syndrome [7]. In addition, prior
studies have shown that the combination of administrative data
with certain clinical data can be used efficiently to stratify surgical
risk [19,20]. Although we used a multivariable regression analysis
to account for the confounding effects of patient and hospital level
variables, the risk adjustment performed is not comprehensive
owing to the lack of adequate patient level data and severity of the
disease process (mild, moderate or severe acute chest syndrome) in
the NIS dataset. However, a number of chronic conditions beyond
sickle cell disease and admission type (elective, urgent) were used
for disease severity adjustment. Also, the nature of the dataset
precludes us from assessing the impact of certain factors that are
known to influence outcomes such as long term treatment with
hydroxyurea, which has been shown to decrease the acute chest
syndrome frequency and mortality [21,22,23]. Hospital readmis-
sions of adult patients with sickle cell anemia are common and are
associated with higher mortality [28]. The lack of patient
identifiers precludes us from identifying readmissions in our study.
Finally, our study results indicate that those with continuous
invasive mechanical ventilation of ,96 hours duration were
associated with a very high odds of in-hospital mortality. The
reasons for high mortality rates in this cohort are multifold and
include: severity of acute chest syndrome, time of starting
mechanical ventilation, or death during mechanical ventilation.
The NIS dataset does not provide information on the severity of
acute chest syndrome, event leading to death, or time of starting
the mechanical ventilation. Consequently, we are unable to
examine these factors.
Despite these limitations, our study reveals that acute chest
syndrome is not an infrequent cause of hospitalization in adults
with sickle cell disease. There was a gradual yearly increase in the
number of hospitalizations due to acute chest syndrome, and an
increase in mechanical ventilation in such patients. Our findings
lend support to the need for better understanding the factors
predisposing to respiratory failure in this growing cohort of the
population.
Conclusions
In this large cohort of hospitalized adults with sickle cell disease
and acute chest syndrome, the need for mechanical ventilation
predicted higher mortality rates and increased hospital resource
utilization. Identification of risk factors may enable optimization of
outcomes.
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